Literature DB >> 24398482

Orbital and central nervous system extension of nasal natural killer/T-cell lymphoma.

Antonio A V Cruz1, Fabiana C P Valera, Lucas Carenzi, Fernando Chahud, Gyl E Barros, Jorge Elias.   

Abstract

BACKGROUND: To describe a case series of nasal natural killer (NK)/T-cell lymphoma (NKTL) with orbital and central nervous system extension.
METHODS: This is a retrospective study. The medical records of 9 patients with a diagnosis of NKTL were reviewed. All patients had a positive biopsy for CD3, CD56, T-cell-restricted intracellular antigen-1, and granzyme expression and CT imaging of nose, sinuses, orbits, and brain. Five patients were also examined with MRI.
RESULTS: Orbital extension occurred in 6 patients. All had extraocular muscle enlargement and 5 showed signs of perineural spread.
CONCLUSIONS: NKTL is a polymorphous disease. Extraocular muscle involvement and perineural spread are overlooked features that explain dissemination of the tumor to both the orbit and the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398482     DOI: 10.1097/IOP.0b013e3182a7500e

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Primary disease sites and patterns of spread in cases of neurolymphomatosis in the orbit associated with lymphoma.

Authors:  Seth J Fritzhand; Bita Esmaeli; Jia Sun; J Matthew Debnam
Journal:  Cancer Imaging       Date:  2021-05-26       Impact factor: 3.909

2.  Extranodal natural killer/T-cell lymphoma nasal type with central nervous system involvement mimicked tuberculous meningitis: A case report.

Authors:  Yina Yang; Zhouling Li; Chen Zhiyang; Hui Liang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Clinical and magnetic resonance imaging features of lymphoma involving the nervous system in cats.

Authors:  Alexane Durand; Erin Keenihan; Daniela Schweizer; Arianna Maiolini; Julien Guevar; Anna Oevermann; Rodrigo Gutierrez-Quintana
Journal:  J Vet Intern Med       Date:  2022-01-20       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.